動態

• 

  Mary Grace N. Tamio   shared news

  在 November 08 2025 at 07:50 PM 已編輯 public

  Unbiased combination screening on repurposed drugs reveals synergistic potential of copanlisib and cerivastatin against chemoresistant high-grade serous ovarian cancer
  
  #ovariancancer #cancer #journals #articles
  
  More info | ⬇️

  

  Unbiased combination screening on repurposed drugs reveals synergistic potential of copanlisib and cerivastatin against chemoresistant high-grade serous ovarian cancer

  High-grade serous ovarian cancers (HGSOCs) are challenging to treat and often resistant to therapy. Despite ongoing therap...
  comment 留言  thumb_up 0 share 分享
• 

  Mary Grace N. Tamio   shared news

  在 May 08 2025 at 07:37 PM 已編輯 public

  A comprehensive overview of ovarian cancer stem cells: correlation with high recurrence rate, underlying mechanisms, and therapeutic opportunities
  
  #ovariancancer #stemcells #journals #articles
  
  More info | ⬇️

  

  A comprehensive overview of ovarian cancer stem cells: correlation with high recurrence rate, underlying mechanisms, and therapeutic opportunities

  Ovarian cancer is one of the most lethal gynecological malignancies, with a recurrence rate of 70–80%, particularly ...
  comment 留言  thumb_up 0 share 分享
• 

  Mary Grace N. Tamio   shared news

  在 April 19 2025 at 10:27 PM 已編輯 public

  Disparities in facility-level adoption of minimally invasive interval debulking surgery for advanced ovarian cancer
  
  #ovariancancer #debulkingsurgery #journals #articles
  
  More info | ⬇️

  Disparities in facility-level adoption of minimally invasive interval debulking surgery for advanced ovarian cancer

  Surgical deescalation is emerging as an optimal approach to reduce treatment burden and minimize morbidity without worseni...
  comment 留言  thumb_up 0 share 分享